Traditionally, models of RRMS pathogenesis were based on the central role of inflammatory Th1 lymphocytes and anti-inflammatory Th2 helper lymphocytes (counter-regulation) after the IFNγ findings in MS lesions. The gene discussed is IFNG; the disease is relapsing-remitting multiple sclerosis.